Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Adial Pharmaceuticals, Inc. stock logo
ADIL
Adial Pharmaceuticals
$0.38
+2.1%
$0.38
$0.22
$1.30
$8.30M14.09 million shs685,614 shs
Aditxt, Inc. stock logo
ADTX
Aditxt
$1.04
+1.0%
$1.20
$0.81
$9,800.00
$2.21M1.51.56 million shs135,760 shs
Addex Therapeutics Ltd. Sponsored ADR stock logo
ADXN
Addex Therapeutics
$8.03
-0.8%
$8.52
$6.51
$13.27
$8.51M1.631,088 shs492 shs
AEON Biopharma, Inc. stock logo
AEON
AEON Biopharma
$0.77
+11.6%
$0.77
$0.38
$115.57
$8.70M0.711.63 million shs115,767 shs
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Adial Pharmaceuticals, Inc. stock logo
ADIL
Adial Pharmaceuticals
+0.03%-5.68%-20.91%-46.06%-62.03%
Aditxt, Inc. stock logo
ADTX
Aditxt
-0.96%0.00%-16.94%-40.80%-99.99%
Addex Therapeutics Ltd. Sponsored ADR stock logo
ADXN
Addex Therapeutics
-2.97%-0.37%-1.67%-3.26%+5.33%
AEON Biopharma, Inc. stock logo
AEON
AEON Biopharma
-0.62%-11.54%-14.18%+29.21%-99.01%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Adial Pharmaceuticals, Inc. stock logo
ADIL
Adial Pharmaceuticals
1.8781 of 5 stars
3.52.00.00.01.90.00.6
Aditxt, Inc. stock logo
ADTX
Aditxt
0.598 of 5 stars
0.04.00.00.01.60.00.6
Addex Therapeutics Ltd. Sponsored ADR stock logo
ADXN
Addex Therapeutics
2.3777 of 5 stars
3.53.00.00.00.00.80.6
AEON Biopharma, Inc. stock logo
AEON
AEON Biopharma
2.9462 of 5 stars
3.55.00.00.00.00.01.9
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Adial Pharmaceuticals, Inc. stock logo
ADIL
Adial Pharmaceuticals
3.00
Buy$8.002,004.71% Upside
Aditxt, Inc. stock logo
ADTX
Aditxt
0.00
N/AN/AN/A
Addex Therapeutics Ltd. Sponsored ADR stock logo
ADXN
Addex Therapeutics
3.00
Buy$30.00273.83% Upside
AEON Biopharma, Inc. stock logo
AEON
AEON Biopharma
3.00
Buy$360.0046,659.32% Upside

Current Analyst Ratings Breakdown

Latest ADTX, ADIL, AEON, and ADXN Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/20/2025
Adial Pharmaceuticals, Inc. stock logo
ADIL
Adial Pharmaceuticals
Zacks Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
(Data available from 8/22/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Adial Pharmaceuticals, Inc. stock logo
ADIL
Adial Pharmaceuticals
N/AN/AN/AN/A$0.26 per shareN/A
Aditxt, Inc. stock logo
ADTX
Aditxt
$12.05K182.96N/AN/A$5.66 per share0.18
Addex Therapeutics Ltd. Sponsored ADR stock logo
ADXN
Addex Therapeutics
$460K18.49N/AN/A$10.37 per share0.77
AEON Biopharma, Inc. stock logo
AEON
AEON Biopharma
N/AN/AN/AN/A($4.12) per shareN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Adial Pharmaceuticals, Inc. stock logo
ADIL
Adial Pharmaceuticals
-$13.20M-$1.05N/AN/AN/AN/A-191.31%-153.59%N/A
Aditxt, Inc. stock logo
ADTX
Aditxt
-$34.45MN/A0.00N/A-206,431.38%-316.98%-80.88%N/A
Addex Therapeutics Ltd. Sponsored ADR stock logo
ADXN
Addex Therapeutics
$8.02M-$0.34N/AN/A3,584.49%-54.27%-49.15%9/1/2025 (Estimated)
AEON Biopharma, Inc. stock logo
AEON
AEON Biopharma
-$36.63M-$6.084.28N/AN/AN/AN/A-994.63%N/A

Latest ADTX, ADIL, AEON, and ADXN Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/14/2025Q2 2025
Aditxt, Inc. stock logo
ADTX
Aditxt
N/A-$3.45N/A-$3.45N/AN/A
8/13/2025Q2 2025
Adial Pharmaceuticals, Inc. stock logo
ADIL
Adial Pharmaceuticals
-$0.22-$0.18+$0.04-$0.18N/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Adial Pharmaceuticals, Inc. stock logo
ADIL
Adial Pharmaceuticals
N/AN/AN/AN/AN/A
Aditxt, Inc. stock logo
ADTX
Aditxt
N/AN/AN/AN/AN/A
Addex Therapeutics Ltd. Sponsored ADR stock logo
ADXN
Addex Therapeutics
N/AN/AN/AN/AN/A
AEON Biopharma, Inc. stock logo
AEON
AEON Biopharma
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Adial Pharmaceuticals, Inc. stock logo
ADIL
Adial Pharmaceuticals
N/A
5.02
5.02
Aditxt, Inc. stock logo
ADTX
Aditxt
N/A
0.02
0.08
Addex Therapeutics Ltd. Sponsored ADR stock logo
ADXN
Addex Therapeutics
N/A
3.02
3.02
AEON Biopharma, Inc. stock logo
AEON
AEON Biopharma
N/A
0.22
0.22

Institutional Ownership

CompanyInstitutional Ownership
Adial Pharmaceuticals, Inc. stock logo
ADIL
Adial Pharmaceuticals
16.41%
Aditxt, Inc. stock logo
ADTX
Aditxt
15.54%
Addex Therapeutics Ltd. Sponsored ADR stock logo
ADXN
Addex Therapeutics
16.14%
AEON Biopharma, Inc. stock logo
AEON
AEON Biopharma
22.78%

Insider Ownership

CompanyInsider Ownership
Adial Pharmaceuticals, Inc. stock logo
ADIL
Adial Pharmaceuticals
4.26%
Aditxt, Inc. stock logo
ADTX
Aditxt
0.01%
Addex Therapeutics Ltd. Sponsored ADR stock logo
ADXN
Addex Therapeutics
15.00%
AEON Biopharma, Inc. stock logo
AEON
AEON Biopharma
0.86%
CompanyEmployeesShares OutstandingFree FloatOptionable
Adial Pharmaceuticals, Inc. stock logo
ADIL
Adial Pharmaceuticals
2021.83 million20.90 millionNo Data
Aditxt, Inc. stock logo
ADTX
Aditxt
602.12 million2.12 millionNo Data
Addex Therapeutics Ltd. Sponsored ADR stock logo
ADXN
Addex Therapeutics
301.06 million901,000Not Optionable
AEON Biopharma, Inc. stock logo
AEON
AEON Biopharma
511.31 million74.37 millionNot Optionable

Recent News About These Companies

AEON Biopharma, Inc. (AEON) - Yahoo Finance
Aeon Biopharma CEO to Step Down Next Week
AEON Biopharma Announces CEO Transition

New MarketBeat Followers Over Time

Media Sentiment Over Time

Adial Pharmaceuticals stock logo

Adial Pharmaceuticals NASDAQ:ADIL

$0.38 +0.01 (+2.15%)
Closing price 04:00 PM Eastern
Extended Trading
$0.37 -0.01 (-1.87%)
As of 06:54 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its lead product is AD04, a serotonin-3 antagonist, which is in Phase III clinical trial for the treatment of alcohol use disorder. The company also focuses on developing drug candidates for non-opioid pain reduction and other diseases and disorders. Adial Pharmaceuticals, Inc. was founded in 2010 and is based in Charlottesville, Virginia.

Aditxt stock logo

Aditxt NASDAQ:ADTX

$1.04 +0.01 (+0.97%)
Closing price 03:59 PM Eastern
Extended Trading
$1.06 +0.02 (+2.40%)
As of 06:15 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Aditxt, Inc., a biotech company, engages in the development and commercialization of technologies that focus on improving the health through monitoring and modulating the immune systems. The company develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its tissues. It also develops ADI-100 for skin grafting, psoriasis, type 1 diabetes, and multiple sclerosis. Aditxt, Inc. has a license agreement with Loma Linda University and Leland Stanford Junior University. The company was formerly known as ADiTx Therapeutics, Inc. and changed its name to Aditxt, Inc. in July 2021. Aditxt, Inc. was incorporated in 2017 and is headquartered in Richmond, Virginia.

Addex Therapeutics stock logo

Addex Therapeutics NASDAQ:ADXN

$8.02 -0.07 (-0.80%)
Closing price 03:43 PM Eastern
Extended Trading
$8.02 0.00 (0.00%)
As of 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Addex Therapeutics Ltd discovers, develops, and commercializes small-molecule pharmaceutical products for central nervous system (CNS) disorders in Switzerland. The company focuses on the discovery of G-protein coupled receptors and enzymes. Its lead programs include Dipraglurant for the treatment of Parkinson's disease levodopa-induced dyskinesia and dystonia, and post-stroke/TBI recovery; ADX71149, a novel orally active metabotropic glutamate receptor subtype 2 positive allosteric modulator (mGlu2 PAM) for the treatment of epilepsy; and GABAB PAM for the treatment of pain, anxiety, overactive bladder, and addiction, as well as substance use disorder. Addex Therapeutics Ltd has license and collaboration agreement with Janssen Pharmaceuticals Inc. for the discovery, development, and commercialization of novel mGlu2 PAM compounds for the treatment of CNS and related diseases; license and research agreement with Indivior PLC discovery, development, and commercialization of novel GABAB PAM compounds for the treatment of addiction and other CNS diseases; and The CharcotMarieTooth Association to evaluate the role of GABAB PAM compounds in preclinical models of CMT1A. The company was formerly known as Addex Pharmaceuticals Ltd. Addex Therapeutics Ltd was founded in 2002 and is based in Geneva, Switzerland.

AEON Biopharma stock logo

AEON Biopharma NASDAQ:AEON

$0.77 +0.08 (+11.58%)
Closing price 04:00 PM Eastern
Extended Trading
$0.73 -0.04 (-5.05%)
As of 06:33 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

AEON Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on developing botulinum toxins. It develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, which completed Phase 2 study for the treatment of cervical dystonia and has an ongoing Phase 2 study for the treatment of both chronic and episodic migraine, as well as develops ABP-450 for the treatment of gastroparesis and posttraumatic stress disorder. The company is based in Irvine, California.